Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ketamine Clinics Los Angeles Partners with FireflyVR for Enhanced Patient Care Using Virtual Reality Preparation and Integration


News provided by

Ketamine Clinics Los Angeles

Oct 07, 2024, 12:05 ET

Share this article

Share toX

Share this article

Share toX

Ketamine Clinics Los Angeles: Pioneering Hope
Ketamine Clinics Los Angeles: Pioneering Hope

The collaboration integrates digital mindfulness experiences with evidence-based mental health treatments

LOS ANGELES, Oct. 7, 2024 /PRNewswire-PRWeb/ -- Ketamine Clinics Los Angeles (KCLA), a pioneer in Ketamine Infusion Therapy and comprehensive mental health care, has announced a collaboration with FireflyVR, a medical technology firm harnessing the power of immersive virtual reality experiences to radically improve treatment and care for behavioral health conditions across the care continuum.

FireflyVR's platform, The Sanctuary, immerses patients in dynamic settings to enhance therapeutic experiences, coupled with evidence-based digital therapy programming that promotes focus, mindset cultivation, and cognitive behavioral changes.

With the support of FireflyVR, we're proud to expand upon our existing preparation and integration program, which our licensed medical professionals exclusively provide to ensure safe, effective treatment for our patients.

Post this

The partnership will enhance KCLA's preparation and integration program for patients undergoing ketamine infusions for depression and other mental health conditions. KCLA's medical team will employ FireflyVR's Sanctuary VR platform to engage patients in immersive mindfulness exercises such as breathwork and body scans, guided meditations, intention setting, releasing negative habits and feelings, and more. The library of educational content developed by KCLA and Firefly will help patients understand what to expect during their treatment journey. Patients will be able to reflect on their ketamine experiences in the virtual world of FireflyVR, check in on how they are feeling, and participate in engaging activities to improve therapeutic outcomes.

"With the support of FireflyVR, we're proud to expand upon our existing preparation and integration program, which our licensed medical professionals exclusively provide to ensure safe, effective treatment for our patients. Leveraging the latest technologies to enhance care is our passion as we continue our mission of revolutionizing mental health care," said Sam Mandel, CEO and Co-founder of KCLA. "Our entire team has undergone extensive training in preparation and integration to offer compassionate care for patients undergoing ketamine infusions. This cutting-edge tool will enhance the world-class treatment KCLA patients already receive daily."

FireflyVR harnesses guided VR to promote neural activity that retrains and restores functional plasticity, engaging patients and enhancing their receptiveness to treatment during the pre-and-post treatment phases of Ketamine Infusion Therapy.

"Our Virtual Reality (VR) environments actively engage the brain, guiding patients to reset behaviors and immerse themselves in transformative practices like deep breathing, cognitive exercises, and mindfulness," said Shel Mann, CEO of FireflyVR. "We are thrilled to expand our offering at KCLA and to begin empowering ketamine infusion patients with an innovative set of tools that support their healing journey."

ABOUT KETAMINE CLINICS LOS ANGELES

Ketamine Clinics Los Angeles (KCLA), co-founded in 2014 by Dr. Steven L. Mandel and Sam Mandel, is a world-renowned pioneer in Ketamine Infusion Therapy and comprehensive mental health care. Operating from a state-of-the-art 5,000-square-foot center in Los Angeles, KCLA is the first and only ketamine clinic accredited by Quad A. With over 30,000 infusions administered and more than 6,000 patients treated, KCLA reports an 83% success rate in treating various mental health conditions, including depression, anxiety, PTSD, and others. The clinic's multidisciplinary team, led by board-certified anesthesiologists, psychiatrists, and other specialized medical professionals, offers personalized treatment plans incorporating Ketamine Infusion Therapy, Transcranial Magnetic Stimulation (TMS), and Psychiatric Medication Management. KCLA accepts 12 of California's largest health insurance networks. With a commitment to innovation, accessibility, and compassion, they are a modern mental health care leader.

ABOUT FIREFLY VR

FireflyVR is a software platform company leveraging virtual reality (VR) and digital health technology across various healthcare verticals. Their vision is to expand the accessibility and efficacy of mental health treatments through innovation. Their mission is reimagining behavioral health and digital therapies, wearable biosensor technology, and immersive virtual environments to develop next-generation products and improve mental healthcare treatment.

Media Contact

Brad Burge, Ketamine Clinics Los Angeles, 1 6508636887, [email protected], https://ketamineclinics.com

SOURCE Ketamine Clinics Los Angeles

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.